Patrizio Lancellotti
Latest contributions
Assessment and management of patients with multivalvular disease involving the tricuspid valve
22 May 2025 – From EuroPCR 2025
Gain expertise on managing multivalvular disease involving the tricuspid valve by understanding diagnostic challenges, intervention indications, and associated pathophysiological factors. This session includes complex case studies focusing on combined valvular lesions and guideline limitations.
Tricuspid hotline: new devices
22 May 2025 – From EuroPCR 2025
Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.
TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3
21 May 2025 – From EuroPCR 2025
Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.
Right ventricule and tricuspid regurgitation: a linked faith
21 May 2025 – From EuroPCR 2025
Investigate the interconnected pathophysiology of right ventricular function and tricuspid regurgitation. This session reviews predictors of outcomes post-transcatheter tricuspid valve repair, the impact of disproportionate regurgitation, and changes in ventricular contraction patterns.
Optimizing case selection and procedure guidance in transcatheter mitral valve interventions
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
This session examines the critical aspect of case selection for various transcatheter mitral valve interventions, ranging from TEER in secondary mitral regurgitation to balloon valvotomy in mitral stenosis and transcatheter mitral valve replacement. It explores the intricacies of procedure planning and guidance for TEER, alongside methods...
The aortic regurgitation problem: an imaging and practical perspective
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
In this session, discover strategies to address biases in aortic regurgitation, influenced by factors like etiology, natural history, surgical risk, age, and gender, and explore an imaging-centric approach to better quantify aortic regurgitation and comprehend its relationship with left ventricular remodeling and outcomes. Anticipate forthcoming guidelines...
EuroPCR 2023 Hotlines/Late-Breaking Trials: mitral and tricuspid valves disease
17 May 2023 – From EuroPCR 2023
The presenters share their views on a range of essays and studies. Join them for an update on: Early experience with a d-shape, monoleaflet TMVR system; Outcomes of Mitral Valve-in-Valve, Mitral Valve-in-Ring and Valve-in-Mitral Annular; Calcification: prospective MITRAL; DRAGONFLY-DMR: transcatheter repair by DragonFly device in mitral...
Innovations in transcatheter tricuspid valve intervention - LIVE case
28 Nov 2022 – From PCR London Valves 2022
Watch two very innovative tricuspid cases you've never seen before:
- Part 1: TR replacement
An 82-year-old male with chronic atrial fibrillation and completely PM dependent for 27 years, presents a symptomatic torrential TR and an enlarged annulus with a great gap. The operators implanted for the first time in...
Aortic valve disease: guidelines and beyond
22 Nov 2021 – From PCR London Valves 2021
Through this PCR London Valves 2021 session, compare the new ESC aortic valve disease guidelines with the US guidelines, focus on controversies and uncertainties of these AVD guidelines, see how to apply the guidelines using the Heart Team decision-making concept, and appreciate in a live case...
Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4
19 May 2021 – From EuroPCR 2021
Watch this session presented by Francesco Maisano, Philipp Lurz, Fabien Praz, Patrizio Lancellotti and Georg Nickenig in order to learn about patient diagnosis and selection for tricuspid transcatheter treatment with TriClip, about latest clinical data supporting TriClip therapy, and about real life experience and attest product innovation: TriClip G4.
Annular reduction using the Cardioband system to treat tricuspid regurgitation
Tricuspid regurgitation is notoriously hard to manage, with limited medical treatment options. What are the therapeutic options available and how can the risks to patients of treatment be reduced? Patrizio Lancellotti (Belgium) talks to Stephan Baldus (Germany) and Claudius Jacobshagen (Germany) about the Cardioband tricuspid valve...
Innovations in TAVI: new valves, new procedures
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the innovations in TAVI from 2019, regarding valves and procedures, such as AorticLab system, FACTA technology, and more!
All you need to know about tricuspid interventions
23 May 2019 – From EuroPCR 2019
Consult this session on tricuspid regurgitation to learn all about the specific anatomy and mechanism of this pathology, the clinical challenges it brings, and also various options for an efficient treatment.
Hotline: new developments in TAVI
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about the latest developments in TAVI: discover new studies' results and novel transcatheter heart valves' clinical outcomes.
Addressing tricuspid regurgitation with annular reduction: the Cardioband tricuspid system
22 May 2019 – From EuroPCR 2019
Consult this session to understand how patients with tricuspid regurgitation and annular dilatation can benefit from Cardioband system...
